PYC THERAPEUTICS LIMITED - Charts / Financials

3.03%

$1.28

Market Cap $746.5M

Healthcare Biotechnology

PYC Therapeutics Limited is an Australia-based clinical-stage biotechnology company... PYC Therapeutics Limited is an Australia-based clinical-stage biotechnology company creating a new generation of ribonucleic acid (RNA) therapies to change the lives of patients with genetic diseases. The Company utilizes its proprietary drug delivery platform to enhance the potency of precision medicines within the rapidly growing and commercially proven RNA therapeutic class. Its drug development programs target monogenic diseases - the indications with the highest likelihood of success in clinical development. Its first-in-class drug programs include Retinitis Pigmentosa type 11, (VP-001), Polycystic Kidney Disease, (PYC-003), Autosomal Dominant Optic Atrophy (ADOA) (PYC-001) and Phelan-McDermid Syndrome (PMS) (PYC-002). The Company's VP-001 program is a lead asset for a blinding eye disease of childhood progressed through multiple patient cohorts in the ongoing single ascending dose clinical trial. ADOA is a progressive and blinding eye disease.More

Actinogen Medical (ASX:ACW) reaches 100th participant milestone in Alzheimer’s Disease Trial & confirms interim analysis timeline.

REFRESH

Last update - 15.59pm 04/07/2025 (20 minute delay)

Day
Open	$1.32		Day High	$1.35		Day Low	$1.28
Daily Volume	579236

Bids				Sellers
Number	Price	Volume		Number	Price	Volume
1	$1.28	4000		3	$1.30	40248

Directors & Senior Management

Dr. Rohan Hockings	Chief Executive Officer, Executive Director
Mr. Andrew Taylor	Chief Financial Officer, Joint Company Secretary
Dr. Glenn Noronha	Chief Development Officer
Mr. Kevin R. Hart	Joint Company Secretary
Mr. Alan Tribe	Non-Executive Chairman of the Board
Mr. Jason Haddock	Non-Executive Independent Director
Dr. Michael Rosenblatt	Non-Executive Independent Director

Data source: Refinitiv

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.28		Change -0.040(3.03%)		Mkt cap ! $746.5M

Open	High	Low	Value	Volume
$1.32	$1.35	$1.28	$764.7K	579.2K

Buyers (Bids)

No.	Vol.	Price($)
1	4000	$1.28

Sellers (Offers)

Price($)	Vol.	No.
$1.30	40248	3

View Market Depth

No.	Vol.	Price($)
1	4000	1.275
1	13987	1.265
2	16060	1.260
1	12000	1.255
2	2800	1.250

Price($)	Vol.	No.
1.300	40248	3
1.330	5000	1
1.345	53113	2
1.350	22000	2
1.360	5958	1

Last trade - 16.10pm 04/07/2025 (20 minute delay)


Last $1.30		Change -0.040 ( 1.89 %)
Open	High	Low	Volume
$1.32	$1.34	$1.30	94289
Last updated 15.59pm 04/07/2025 ?

PYC (ASX) Chart

PYC THERAPEUTICS LIMITED - Charts / Financials

Directors & Senior Management

Buyers (Bids)

Sellers (Offers)

Top Stories